Question 1

What are research peptides?

Accepted Answer

Research peptides are short chains of amino acids — the same building blocks as proteins — synthesized in laboratory settings for use in scientific investigations. Unlike larger protein therapeutics, peptides are typically 2–50 amino acids in length, which confers unique pharmacokinetic properties including targeted receptor binding, relatively rapid degradation, and low immunogenicity. Preclinical studies explore their roles in signaling pathways across metabolic, regenerative, and neuroendocrine systems.

Question 2

How is peptide purity measured and why does it matter?

Accepted Answer

Peptide purity is typically assessed by reverse-phase high-performance liquid chromatography (HPLC) and confirmed by mass spectrometry. Research applications require high purity — commonly ≥98% — to ensure that observed biological effects can be attributed to the intended molecule rather than contaminants. Independent third-party certificates of analysis (COAs) provide an objective record of purity at the time of synthesis.

Question 3

What is a Certificate of Analysis (COA)?

Accepted Answer

A Certificate of Analysis is a document issued by an accredited analytical laboratory confirming the identity, purity, and potency of a synthesized compound. For research peptides, a COA typically includes HPLC chromatograms, mass spectrometry data, amino acid composition analysis, and solubility data. Independent third-party COAs — generated by labs with no financial relationship to the supplier — are considered the gold standard for verifying compound quality in preclinical research.

Question 4

What is BPC-157 and what biological mechanisms have been studied?

Accepted Answer

BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Research has examined its effects on angiogenesis, nitric oxide synthesis, and growth factor receptor modulation. Proposed mechanisms include upregulation of vascular endothelial growth factor (VEGF), interaction with the NO-system to promote vasodilation, and modulation of the dopaminergic and serotonergic neurotransmitter systems. Preclinical studies across rodent models report accelerated tendon-to-bone healing, muscle injury repair, and gastroprotective effects.

Question 5

What is TB-500 (Thymosin Beta-4) and how does it relate to actin dynamics?

Accepted Answer

TB-500 is a synthetic version of the 43-amino acid peptide Thymosin Beta-4 (Tβ4), one of the most abundant peptides in mammalian cells. Its primary structural role is the sequestration of globular actin (G-actin), which regulates actin polymerization dynamics essential for cell migration, proliferation, and wound healing. Research has demonstrated that Tβ4 promotes the migration of keratinocytes and endothelial cells into wound sites, stimulates angiogenesis, and reduces inflammation via down-regulation of NF-κB signaling.

Question 6

What is MOTS-c and how does it relate to mitochondrial signaling?

Accepted Answer

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. It activates AMP-activated protein kinase (AMPK), a central energy-sensing enzyme. Research in mouse models has shown that MOTS-c administration improves insulin sensitivity, reduces high-fat-diet-induced obesity, and extends median lifespan in aged mice. Circulating MOTS-c levels decline with age in humans, making it a subject of longevity research.

Question 7

What is SS-31 and what is its proposed role in mitochondrial membrane protection?

Accepted Answer

SS-31 (elamipretide) is a tetrapeptide that selectively partitions into the inner mitochondrial membrane and binds cardiolipin — a lipid essential for cristae structure and the organization of respiratory chain supercomplexes — thereby reducing electron leak, superoxide generation, and cytochrome c release. Animal models of heart failure and ischemia-reperfusion injury have demonstrated improvements in ATP production and reductions in oxidative stress with SS-31 treatment.

Question 8

What is Retatrutide and what receptor systems does it target?

Accepted Answer

Retatrutide (LY3437943) is a tri-agonist peptide that activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously. Published phase 2 clinical trial data (NEJM, 2023) reported mean body-weight reductions of approximately 17% over 24 weeks at the highest dose studied.

Question 9

What is the CJC-1295 + Ipamorelin combination and why are they studied together?

Accepted Answer

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that significantly extends its plasma half-life by forming a covalent bond with albumin. Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist that stimulates pituitary GH release through a separate receptor pathway. Combining GHRH analog and GHSR agonist targets both primary regulatory inputs to pituitary somatotrophs, producing synergistic GH pulses in preclinical studies while maintaining physiological pulsatility.

Question 10

How are synthetic peptides stored to maintain stability?

Accepted Answer

Lyophilized (freeze-dried) peptides are the most stable form for long-term storage. In powder form, most synthetic peptides remain stable for 12–24 months when stored at −20 °C in a desiccated, light-protected environment. Reconstitution with sterile bacteriostatic water — which contains 0.9% benzyl alcohol as a preservative — allows repeated use from a single vial over several weeks when refrigerated at 2–8 °C.

CJC-1295 + Ipamorelin Research Peptide

Research Applications

Specifications

Research Overview

Certificate of Analysis

Published research